Sarah Luppino, Ph.D.

Thintronics Inc. is reinventing interconnect insulator technologies to unlock next- generation computing, networking and wireless performance. The companys novel materials enable wider bandwidths, increased power efficiency, and highly integrated form factors for advanced computing and communication systems.

Defining the standard for moving information.

The Mind. Unlocked. Work Smarter. Live Better. Through proprietary brain-computer interface (BCI) technology, Neurable is pioneering the future of human-computer interaction by allowing you to use the power of your brain to get more out of your everyday devices.

Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.

M Ventures is a strategic, corporate venture capital fund investing in Biotechnology - with verticals in Healthcare and Life Science tools - and Technology - with verticals in Semiconductors and Displays as well as Sustainable Manufacture.

Thintronics Inc. is reinventing interconnect insulator technologies to unlock next- generation computing, networking and wireless performance. The companys novel materials enable wider bandwidths, increased power efficiency, and highly integrated form factors for advanced computing and communication systems.

Defining the standard for moving information.

The Mind. Unlocked. Work Smarter. Live Better. Through proprietary brain-computer interface (BCI) technology, Neurable is pioneering the future of human-computer interaction by allowing you to use the power of your brain to get more out of your everyday devices.

Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.

M Ventures is a strategic, corporate venture capital fund investing in Biotechnology - with verticals in Healthcare and Life Science tools - and Technology - with verticals in Semiconductors and Displays as well as Sustainable Manufacture.